Abeona Therapeutics reports Q2 ZEVA Skin revenue of $11.4 million
Abeona Therapeutics said Q2 2026 ZEVA Skin revenue was $11.4 million, up 31% from Q1, after treating five patients in the quarter and expanding to seven activated QTCs.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.